Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Passage Bio Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 14 Sep 2021 | Passage Bio Inc Enters Phase I/II Clinical Trial Agreement with CTI Clinical Trial and Consulting Inc for PBFT-02 (GDCT0399540) | Contract Service Agreement |
Passage Bio Inc
|
CTI Clinical Trial and Consulting Inc
|
| 17 Mar 2021 | Passage Bio Inc Enters Phase I/II Clinical Trial Agreement with CTI Clinical Trial and Consulting Inc for PBGM-01 (GDCT0388967) | Contract Service Agreement |
Passage Bio Inc
Passage Bio Inc Passage Bio Inc |
CTI Clinical Trial and Consulting Inc
CTI Clinical Trial and Consulting Inc
CTI Clinical Trial and Consulting Inc
|
| 21 Jan 2021 | Passage Bio Prices Public Offering of Common Stock for USD154 Million | Equity Offering | - |
Passage Bio Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer